A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
10/2002
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085320A1 Two-phase roll-on cosmetic product
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/31/2002	CA2444118A1 Two-phase roll-on cosmetic product
10/30/2002	EP1252893A1 Medicine containing anemonin as effective component for treating aseptic inflammation
10/30/2002	EP1252889A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
10/30/2002	EP1051425B1 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
10/30/2002	EP0695187B1 Inhibition, control and regression of angiogenesis with hyaluronic acid or hyaluronic acid and nsaid
10/30/2002	CN1377253A Stable hydrogenated lupulone antibacterial oral compositions
10/29/2002	CA2014486C Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group
10/24/2002	WO2002083079A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization
10/24/2002	WO2002066019A3 Cancer treatment
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	US20020156284 Crystalline form of omeprazole
10/24/2002	US20020156053 Treating gastro-oesophageal reflux disease
10/24/2002	US20020156037 DNA vaccine formulations
10/24/2002	US20020155078 Two-phase roll-on cosmetic product
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP1250138A1 Fulvestrant formulation
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1159966B1 Composition for the treatment of psoriasis
10/23/2002	EP0772446B1 Anti-adhesion agent
10/23/2002	CN1376053A 皮肤护理组合物 Skin care composition
10/23/2002	CN1376050A Skin care composition
10/22/2002	US6469012 Pyrazolopyrimidinones for the treatment of impotence
10/22/2002	US6468511 Anhydrous cosmetic comprising a naphthalate ester, a volatile silicone based emulsifier, a volatile silicone and active ingredient such as antiperspirant in glycol; efficient, stable
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/17/2002	WO2002080954A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	WO2002080902A1 Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp
10/17/2002	WO2002080873A1 Kits for whitening teeth
10/17/2002	WO2002080861A1 Method for preparing a treatment product and a treatment product
10/17/2002	WO2002080797A1 Vessel sealing instrument
10/17/2002	WO2000000211A3 Hydrocolloids obtained from portulaca oleracea and the use thereof
10/17/2002	US20020151598 Bronchodilating compositions and methods
10/17/2002	US20020151597 Formoterol, or a derivative; long term storage stability
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020150636 Anti-leishmanial activity of betel leaf extract
10/17/2002	US20020150593 Mycoplasma vaccine
10/17/2002	CA2827167A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2606839A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2443223A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2443040A1 Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenyl-sulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp
10/17/2002	CA2442630A1 Kits for whitening teeth
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1098660B1 Encapsulation of water soluble peptides
10/16/2002	CN1374872A Stabilization of macrolides
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/16/2002	CN1092514C Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and ue thereof
10/15/2002	US6465481 Exhibit electrophysiological activity; may be more potent and produce fewer side effects including lower incidence of proarrhythmias such as torsades de pointes
10/15/2002	US6464982 Herbal immune system stimulant
10/15/2002	US6464963 Desensitizing dentifrice containing potassium and tin salts
10/15/2002	US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/10/2002	WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/10/2002	WO2002078638A2 Morpholino imaging and therapy
10/10/2002	WO2002078580A1 Condom with an erectogenic composition
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147201 Glycyrrhizin complex
10/10/2002	US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002	US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/10/2002	US20020147150 Sustained-release preparation
10/10/2002	US20020146666 Kits for whitening teeth
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002	US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002	CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
10/09/2002	EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002	EP1247523A1 Essential fatty acids in the prevention of cardiovascular events
10/09/2002	EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/08/2002	US6461622 Oil in water emulsions containing retinoids
10/08/2002	US6461617 Recombinant toxin fragments
10/08/2002	CA2304275C Hair conditioning composition comprising high molecular weight ester oil
10/08/2002	CA2254145C Improved process to stabilize proteins
10/03/2002	WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002	WO2002076375A2 Process for the preparation of benazepril
10/03/2002	WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002	WO2001003648A9 Oregano-based therapeutic composition
10/03/2002	US20020142996 Use of bisphosphonic acids for treating angiogenesis
10/03/2002	US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002	US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002	US20020141944 Stable pharmaceutical budersonide preparation for producing propellant-free aerosols
10/03/2002	CA2442573A1 Process for the preparation of benazepril
10/02/2002	EP1244661A1 Compounds and methods for the treatment of pain
10/02/2002	EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002	EP1244419A2 Agent for dyeing keratin containing fibers
10/02/2002	EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002	CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002	CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002	CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
10/02/2002	CN1091599C Anti-HIV triple combination
10/01/2002	US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002	US6458811 Benzothiophenes formulations containing same and methods
10/01/2002	US6458391 Treating lesions in livestock
10/01/2002	CA2071520C Elimination of activated lymphocytes
09/2002
09/26/2002	WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors

1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 295